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Cellular metabolism can influence host immune responses to 
Mycobacterium tuberculosis. Using a systems biology approach, 
differential expression of 292 metabolic genes involved in glycol-
ysis, glutathione, pyrimidine, and inositol phosphate pathways 
was evident at the site of a human tuberculin skin test challenge 
in patients with active tuberculosis infection. For 28 metabolic 
genes, we identified single nucleotide polymorphisms that were 
trans-acting for in vitro cytokine responses to M. tuberculosis 
stimulation, including glutathione and pyrimidine metabolism 
genes that alter production of Th1 and Th17 cytokines. Our 
findings identify novel therapeutic targets in host metabolism 
that may shape protective immunity to tuberculosis.
Keywords. tuberculosis; immune response; immunome-
tabolism; metabolism; cytokines; transcriptomics; microarrays; 
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The activity of many cellular metabolic pathways can impact 
the host immune response to infections [1]. Individual met-
abolic pathways have been implicated in antimycobacterial 
responses: glutathione enhances interleukin-12 (IL-12) and 
interferon-gamma (IFN-γ) secretion following Mycobacterium 
tuberculosis stimulation [2]; tryptophan catabolism is involved 
in M.  tuberculosis-induced production of IL-1β and IL-23 [3] 
and control of M. tuberculosis growth [4]; and a shift towards 
aerobic glycolysis in M. tuberculosis-infected macrophages reg-
ulates IL-1β production [5, 6]. However, as metabolic reactions 
are intrinsically interdependent, the challenge lies in determin-
ing the relative roles of these and other pathways during in vivo 
M. tuberculosis infection.
Our group has made use of the human tuberculin skin test 
(TST) challenge model to faithfully reflect the inflammatory 
changes that occur at the site of tuberculosis disease, char-
acterizing the tissue immunological pathways induced early 
after mycobacterial antigen exposure [7]. However, to date, no 
studies have explored the metabolic changes and their func-
tional consequences on downstream cytokine responses in 
such a model. Quantitative cytokine production in response 
to mycobacterial stimulation has been associated with genetic 
polymorphisms [8]. These cytokine quantitative trait loci 
(cQTLs) provide a functional insight into how genetics influ-
ences an inflammatory response, and in turn identify criti-
cal pathways that may be amenable to host-directed therapy. 
In this study, we use the TST model to test the hypothesis 
that differential tissue expression of genes involved in reg-
ulating metabolic pathways can directly influence cytokine 
production following M.  tuberculosis stimulation. In turn, 
our findings provide putative mechanistic links between the 
activity of cellular metabolic pathways and immune effector 
functions.
METHODS
Transcriptomic Data Analysis
Transcriptomes were derived from TST and blood of patients 
with active tuberculosis, and human M.  tuberculosis-in-
fected and healthy lymph nodes from a separate cohort 
(Supplementary Table  S1). All patients were human immu-
nodeficiency virus (HIV) seronegative and none had diabetes 
mellitus.
We used the KEGG pathway database (http://www.genome.
jp/kegg/pathway.html) to derive 33 pathways associated with 
human metabolism, yielding a list of 1422 metabolic genes con-
taining no duplicate genes and no annotation to the original 
pathways (Supplementary Table S2 and Table S3). Bioinformatic 
analyses were performed as previously described [7] (see 
Supplementary Methods).
SNP Extraction and cQTL Mapping
Single nucleotide polymorphisms (SNPs) within metabolic 
genes and cQTLs were identified as previously described [8] 
(see Supplementary Methods).
Metabolite Reporter Analysis
Reporter metabolite analysis [9] was performed in Matlab 
using the RAVEN Toolbox (http://biomet-toolbox.chalmers.
se/index.php?page=downtools-raven) and the human genome-
scale metabolic reconstruction network HMR 2.00 provided in 
Human Protein Atlas (http://www.metabolicatlas.org/down-
loads/hmr) (see Supplementary Methods).
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Metabolite Depletion Experiments
Peripheral blood mononuclear cells (PBMC) were isolated from 
9 healthy Dutch adult volunteers and stimulated with M. tuber-
culosis lysate in the presence or absence of pharmacological 
manipulators of the glutathione pathway (see Supplementary 
Methods).
RESULTS
We have previously demonstrated that the transcriptional 
response at the site of TST is characterized by upregulation 
of 1725 genes that closely reflect changes seen in dissected 
human tuberculosis granuloma relative to healthy lung tis-
sue [7]. We now show that the TST signature is also enriched 
within M. tuberculosis-infected relative to healthy lymph nodes 
(Figure 1A), confirming that the TST transcriptional responses 
mirror pathology seen at established sites of human tuberculo-
sis disease.
Out of 1422 metabolic genes, 292 were differentially 
expressed at the site of TST versus saline injection in patients 
with active tuberculosis disease (Supplementary Figure S1 and 
Supplementary Table S4). Expression of these genes at tissue level 
showed a remarkable lack of concordance with the blood tran-
scriptome of the same patients, as only 9 metabolic genes were 
differentially expressed in the blood (Figure 1B, Supplementary 
Figure S2, and Supplementary Table S5). This demonstrates that 
the TST challenge model provides greater molecular resolution 
to identify host differential metabolic gene expression to myco-
bacterial infection than the blood compartment [7].
Given the interconnected relationship between multiple 
metabolic pathways, we generated a network depicting the 10 
most enriched KEGG annotated metabolic pathways based on 
the 292 differentially expressed metabolic genes (Figure 1C). As 
expected, the TST induced changes in multiple interlinked met-
abolic pathways. These included not only previously described 
pathways such as glycolysis and glutathione metabolism, but 
also others such as inositol phosphate metabolism and specific 
amino acid metabolic pathways not previously associated with 
tuberculosis [1, 2]. Because differentially expressed genes within 
the same metabolic pathway were both up- or downregulated 
(Supplementary Figure S3), we evaluated which metabolites in 
these pathways were most affected using reporter metabolite 
analysis. This identified metabolites in the human metabolic 
network around which the most transcriptional changes occur 
[10]. The model predicted changes in several key metabolites 
between TST and saline, including 1,3-bisphospho-d-glycer-
ate (glycolysis), l-formylkynurenine (tryptophan metabolism), 
1-phosphatidyl-1d-myo-inositol-3,4-bisphosphate, and glu-
tathione (Figure 1D). Therefore, the model predicts that gene 
expression changes in the TST alter the concentration of several 
bioactive metabolites in multiple pathways, and that this has the 
potential to impact the nature of the host immune response to 
M. tuberculosis.
Next, we sought to test the hypothesis that metabolic changes 
in the tissue environment influence M.  tuberculosis-induced 
cytokine production. We used natural genetic variation to 
identify putative cis-acting SNPs for metabolic gene expres-
sion and tested whether they might be trans-acting SNPs for 
cytokine responses. We identified metabolic genes differen-
tially expressed in the TST and assessed their impact on cyto-
kine secretion following M. tuberculosis lysate stimulation in a 
cohort of 500 healthy individuals (500FG cohort) [8]. First, we 
used genotypes extracted from the 1000 Genomes Project to 
identify 16 061 SNPs from the 109 metabolic genes that com-
prised the 10 most enriched metabolic pathways in the TST 
(Figure 1C). We then assessed which of these SNPs were associ-
ated with variable cytokine secretion, generating 2376 putative 
cQTLs. To reduce multiple testing false positives, we focused 
on SNPs in the mRNA coding region of the gene of interest that 
influence the same gene’s transcription (ie, metabolic gene SNPs 
that were cis-expression QTLs [eQTLs]).
This analysis generated 47 cQTL SNPs from 28 metabolic 
genes (Figure 2A, 2B, Supplementary Table S6, and Table S7). 
Based on these genes, the most over-represented metabolic 
pathways included the glutathione, glycolysis, inositol phos-
phate metabolism, and pyrimidine pathways (Supplementary 
Figure  S4). Many amino acid metabolism pathways were 
also observed, and ALDH3A2, ALDH3A1, LDHA, and IL4I1 
were the most frequent constituent genes from these path-
ways (Supplementary Figure S4). Glutathione and pyrimidine 
metabolism predominantly influenced the secretion of IFN-γ 
and IL-17. Seven of 15 (47%) cQTLs that regulated IFN-γ secre-
tion and 4 of 7 (57%) cQTLs that regulated IL-17 secretion 
were derived from genes assigned to glutathione or pyrimidine 
metabolic pathways, whereas no cQTLs from these pathways 
influenced cytokine secretion by macrophages (Figure 2B). In 
contrast, genes involved in glycolysis, amino acid, and inositol 
phosphate metabolism acted as cQTLs more ubiquitously, influ-
encing the secretion of both T-cell and myeloid cell-derived 
cytokines (IL-1β, IL-6, IL-22, and tumor necrosis factor- alpha 
[TNF-α]) (Figure 2B).
We validated some of the relationships between metabolic 
changes and cytokine secretion in vitro using buthionine sulf-
oximine (BSO), an inhibitor of glutathione synthesis, and dieth-
ylmaleate (DEM), which depletes cells of glutathione [11]. Both 
resulted in increased IL-6 and decreased IL-17 secretion by 
M. tuberculosis-stimulated PBMC (Figure 2C), consistent with 
the cQTL data demonstrating that variable expression of glu-
tathione genes impacted the secretion of both these cytokines 
(Figure 2B).
Finally, to explore the physiological relevance of the 28 met-
abolic genes that act as cQTLs, we showed that their expression 
in M.  tuberculosis-infected lymph nodes strongly correlated 
with expression in the TST (Figure 2D), indicating that these 
metabolic genes have the potential to exert cQTL activity at 
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Figure 1. Metabolic pathways enriched in tuberculin skin test (TST) responses relative to saline injection. A, Expression of TST signature in Mycobacterium tuberculosis 
(Mtb)-infected lymph nodes (LN) relative to healthy LN. Each dot represents 1 sample. Horizontal lines represent median value expression. * P < .0001 by Mann-Whitney test. 
B, Pairwise comparison of 292 genes differentially expressed in TST relative to saline injection compared to the expression difference between the blood of patients with 
active tuberculosis (TB) and healthy volunteers (HV). C, The top 10 most statistically enriched KEGG metabolic pathways in the TST relative to saline injection are represented 
in a network plot, in which the edges indicate associations between genes (light gray nodes) and named pathways (dark gray nodes), and the node size is proportional to the 
respective pathway −log10 P value enrichment statistic. D, Reporter metabolites predicted to be differentially expressed in TST compared to saline injection. Metabolites 
selected for known association with metabolic pathways and ranked by increasing P value. Abbreviations: r2, Spearman rank correlation coefficient; CoV, covariance.
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Figure 2. Identification of cytokine quantitative trait loci (cQTLs) within metabolic genes differentially expressed in a tuberculin skin test (TST). A, Representative box plots 
of association between single nucleotide polymorphisms (SNP) genotypes and Mycobacterium tuberculosis (Mtb)-induced cytokine levels. Length of the box is the interquar-
tile range and whiskers indicate the range of 1.5 × the length of the box from either end of the box. P values were obtained using linear regression analysis of cytokine on 
genotype data. B, Heatmap of all 47 cQTL SNPs and their relationship to cytokine secretion following peripheral blood mononuclear cell (PBMC) or macrophage (Mfs) stimula-
tion with M. tuberculosis lysate. C, Interleukin-6 (IL-6) and IL-17 secretion from M. tuberculosis lysate-stimulated PBMC in the presence or absence of buthionine sulfoximine 
(BSO) or diethylmaleate (DEM). Horizontal lines represent median value expression. * P < .01 Wilcoxon signed-rank test. D, Gene expression of 28 metabolic genes with cQTL 
SNPs in tuberculin skin test (TST) relative to saline injection compared to the expression in M. tuberculosis-infected lymph nodes (TBLN) relative to healthy lymph nodes (LN). 
Abbreviations: IFN-γ, interferon-gamma; r2, Spearman rank correlation coefficient; RPMI, RPMI 1640 medium; TNF-α, tumor necrosis factor-alpha.
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the site of human tuberculosis disease, thus shaping the local 
inflammatory response to M. tuberculosis.
Discussion
Individual metabolic pathways have been shown to affect the 
host response to M. tuberculosis [2, 3, 5], but their relative con-
tribution in a multicellular tissue infection setting has not been 
investigated. We took a systems approach using the human in 
vivo TST challenge model, revealing gene expression changes in 
multiple metabolic pathways that in turn predict enrichment of 
several bioactive metabolites. Genetic polymorphisms in these 
differentially expressed metabolic genes, as well as pharmaco-
logical inhibition, were found to control M. tuberculosis-induced 
cytokine production. Finally, expression of these same genes 
at the site of tuberculosis disease closely correlated with that 
observed in the TST, underlying the functional relevance of our 
findings to the pathogenesis of human tuberculosis infection.
The inflammatory response to TST challenge reflects the 
immunopathological changes in human tuberculosis disease 
[7]. Interestingly, in terms of metabolic gene expression, the TST 
site also closely mirrors M. tuberculosis-infected lymph nodes, 
unlike the peripheral blood of tuberculosis patients, which 
showed quantitatively smaller changes. Although this may 
reflect the TST response occurring after acute antigenic chal-
lenge in contrast to steady-state assessment in blood, in these 
same patients the blood transcriptome shows significant devia-
tion from health [7, 12], illustrating that tissue may be the more 
appropriate context when studying changes in metabolism.
We observed differential gene expression in the TST of mul-
tiple metabolic pathways, including glycolysis, glutathione, 
pyrimidine, and inositol phosphate metabolism. The relevance 
of changes in the metabolic environment after M.  tuberculo-
sis infection was supported by the fact that we identified sev-
eral SNPs in these genes that both act as cis-eQTLs and also 
impact M.  tuberculosis-induced cytokine secretion by PBMC 
and macrophages [8], cells that are enriched at the site of TST 
[7]. For functional validation, we selected one of the path-
ways identified through gene expression and cQTL analysis, 
the glutathione pathway, whereby pharmacological inhibition 
affected M. tuberculosis-induced production of IL-6 and IL-17. 
Importantly, the 500FG cohort data demonstrated that vari-
able expression of genes involved in glutathione metabolism 
(GSTM2, ANPEP, LAP3, and GSTA3) impacted the secretion of 
these same cytokines. Furthermore, we have previously demon-
strated that inhibiting glycolysis using 2-deoxyglucose impaired 
IL-22 secretion by M.  tuberculosis-stimulated PBMC, in turn 
validating the observation from the 500FG data that SNPs in 
the glycolysis gene ADPGK are cQTLs for IL-22 secretion [6].
Our analyses also identified new roles for pyrimidine 
metabolism, which has recently been associated with regu-
lating inflammasome activity and cytokine secretion [13]. 
We demonstrate that pyrimidine and glutathione metabolism 
genes predominantly impact the secretion of T-cell–derived 
cytokines IFN-γ and IL-17. As such, therapeutic manipulation 
of pyrimidine and glutathione pathways may influence T helper 
(TH1) and TH17 polarization, and thus the balance between pro-
tection and pathology in M. tuberculosis-infected tissues [14]. In 
contrast, genes involved in amino acid and inositol phosphate 
metabolism impact a wider array of cytokines, including those 
secreted from myeloid cells, which may in part relate to the cen-
tral role of the metabolite phosphatidylinositol as the backbone 
of signal transduction components inositol triphosphate (IP3) 
and protein kinase B (Akt) [6].
Our study has some limitations. Firstly, we restricted our 
cQTL analyses to SNPs that were also cis-eQTLs to limit mul-
tiple testing errors, thus likely missing other functionally rel-
evant cQTLs that may act in trans via other genes. Equally, 
identification of SNPs that were eQTLs was limited to databases 
that probed blood and tissues not infected with M. tuberculo-
sis, possibly missing other functionally relevant SNPs in the 
context of M. tuberculosis infection. Furthermore, the effector 
cytokines studied for cQTL analysis comprise only one facet 
of the host immune response to M. tuberculosis infection and 
were restricted to the manually selected panel available in the 
500FG database, introducing bias into the breadth of immu-
nological effector functions exerted by metabolic gene SNPs. 
Finally, although reporter metabolite analysis predicted com-
putationally that the gene expression changes impacted on the 
concentration of several key metabolites, we were not able to 
assess this directly. The study was conceived retrospectively, and 
thus tissue samples had already been used wholly for transcrip-
tomic analysis. The relationship between tissue gene expression 
changes and metabolite concentrations will need to be verified 
experimentally in future studies.
In summary, this study made a comprehensive assessment of 
the human tissue metabolic transcriptional response to in vivo 
mycobacterial antigenic stimulation. A number of known and 
novel metabolic pathways were differentially expressed, and 
genetic variation in identified genes affected cytokine responses 
to M. tuberculosis. Therefore, our systems approach provided a 
novel list of putative metabolic gene cQTLs that are amenable 
to further experimental validation, and revealed a new layer of 
complexity to the host antimycobacterial response, supporting 
the use of host-directed strategies that target cellular metab-
olism, such as the regulation of glycolysis by metformin [15]. 
Furthermore, our approach combining transcriptomics and 
functional genomics illustrates a pipeline that can be used to 
identify novel and clinically relevant pathways in the context of 
other infectious diseases.
Supplementary Data
Supplementary materials are available at The Journal of Infectious 
Diseases online. Consisting of data provided by the authors to 
benefit the reader, the posted materials are not copyedited and 
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